According to MarketsandMarkets™, the fungicides market is estimated at USD 26.87 billion in 2026 and is projected to reach USD 36.91 billion ...
Plant biotechnology can be defined as the introduction of desirable traits into plants through genetic modification.
Bioinsecticide innovator advances lead aphid product toward regulatory approval, demonstrating technology resilience under ...
Hosted on MSN
Lilly, Mubadala Bio announce landmark agreement to advance pharmaceutical contract manufacturing in Abu Dhabi
ABU DHABI, 20th October, 2026 (WAM) -- Eli Lilly and Company (Lilly) and Mubadala Bio today announced a strategic collaboration to advance the localised packaging and logistics of Lilly’s GLP-1 ...
19 October 2026, São Paulo: Dutch biologicals company Koppert has launched Macan, a biological foliar fungicide, for the ...
INmune Bio Inc. and Quantum Computing Inc. partner to explore how AI and quantum computing can advance Alzheimer’s drug research. INmune Bio Inc. and Quantum Computing Inc. Boca Raton, Florida, ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, today announced a research collaboration and licensing ...
INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro ...
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE)-- Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, and Barnwell Bio, an animal health intelligence company, today ...
合作結合INmune Bio的臨床研究與QCi的Dirac-3S量子優化機，以找出XPro潛在新治療適應症及生物標記 此初步合作為QCi在製藥及生物科技市場的首個商業客戶，擴展量子計算在藥物開發的應用 INmune Bio ...
Merck's $550 million regional investment reinforces ongoing commitment to U.S. R&D while strengthening its long-standing footprint in Pennsylvania RAHWAY N.J., Oct. 14, 2026 - Merck (NYSE: MRK), known ...
Collaboration combines INmune Bio’s clinical research with QCi’s Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results